The DOI matches its Crossref record; 34 of the 37 references it cites were found in a registry or an index.
All progestins are not created equal
Abstract
A variety of progestins are available for therapeutic use. It is convenient to classify them into those related in chemical structure to progesterone or testosterone. Progestins related to progesterone can be subdivided into pregnanes and 19-norpregnanes, whereas those related to testosterone can be subdivided into those with and without a 17-ethinyl group. 17-Ethinylated progestins consist of the families of norethindrone (estranes) and levonorgestrel (13-ethylgonanes). Progestins administered orally undergo extensive hepatic first pass metabolism primarily by reduction and conjugation, and in most instances, relatively high progestin doses are required for therapeutic use. There are limited reliable data on the pharmacokinetics of most progestins. Some progestins are prodrugs, requiring transformation prior to exhibiting progestational activity. Qualitative and quantitative tests utilizing either human or animal species have been used to establish progestin potency. However, profound differences in progestational activity are often observed between human and animal tissues. Also, there is a misconception about androgenicity of progestins due largely to extrapolation of data from rat studies to the human. Progestins differ widely in their chemical structures, structure-function relationships, metabolism, pharmacokinetics, and potencies; they are not created equal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Progestogens are primarily metabolized by the liver largely to form pregnanediols and pregnanolones [336,337].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [337]
Citations
Cites
Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-484_1 · Cited by 413
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
Krattenmacher, R. (2000) · Contraception · doi:10.1016/s0010-7824(00)00133-5 · Cited by 375
Treatment of the Postmenopausal Woman
Løbo, R. A., Taylor, A. E., & Schlechte, J. (1995) · The Endocrinologist · doi:10.1097/00019616-199501000-00012 · Cited by 194
Simon, J. A., Robinson, D. E., Andrews, M. C., Hildebrand, J. R., Rocci, M. L., Blake, R. E., & Hodgen, G. D. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56031-2 · Cited by 151
Assessment of the potency of orally administered progestins in women
King, R. J. B., & Whitehead, M. I. (1986) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49880-8 · Cited by 127
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids
Stanczyk, F. Z., & Roy, S. (1990) · Contraception · doi:10.1016/0010-7824(90)90093-b · Cited by 122
Phillips, A., Demarest, K. T., Hahn, D. W., Wong, F. A., & McGuire, J. L. (1990) · Contraception · doi:10.1016/0010-7824(90)90039-x · Cited by 119
Effect of low-dose oral contraceptives on androgenic markers and acne
Thorneycroft, I. H., Stanczyk, F. Z., Bradshaw, K. D., Ballagh, S. A., Nichols, M. D. N., & Weber, M. E. (1999) · Contraception · doi:10.1016/s0010-7824(99)00093-1 · Cited by 112
Pharmacokinetics and Potency of Progestins used for Hormone Replacement Therapy and Contraception
Stanczyk, F. Z. (2002) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1020072325818 · Cited by 108
Kuhnz, W., Heuner, A., Humpel, M., Seifert, W., & Michaelis, K. (1997) · Contraception · doi:10.1016/s0010-7824(97)00174-1 · Cited by 106
Flagged first, then by citations
3 of the 37 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Stanczyk, 1989, Pharmacokinetics of progestogens, Int. Proc. J., 1, 11
- Stanczyk, 1996, Introduction: structure–function relationships, metabolism, pharmacokinetics and potency of progestins, Drugs Today, 32, 1
- Kuhnz, 1993, Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing oral contraceptive to 12 women, Contraception, 47, 283
- Oettel, 1995, A 19-norprogestin without a 17α-ethinyl group. I. Dienogest from a pharmacokinetic point of view, Drugs Today, 31, 499
- Teichman AT. Levonorgestrel, vol. 43. Stuart-George Thieme Verlag; 1990.
Cited by
Sorted by citations
Items 201–226 of 226
Endometrial Cancer Prevention with Levonorgestrel-Releasing Intrauterine System
Wildemeersch, D. A., Jóźwik, M., & Jóźwik, M. (2015) · InTech eBooks · doi:10.5772/59211
“[40, 41]”
Kriek, W. J. (2005) · SUNScholar (Stellenbosch University)
Ahmed, H., Cheng, W., & Ou, B. (2013) · Bangladesh Veterinarian · doi:10.3329/bvet.v30i1.16280
“Synthetic progestogens exert similar effects to progesterone, although their chemical structure, efficiency and pharmacokinetic properties differ (Stanczyk, 2003; Sitruk-Ware, 2004).”
BackgroundResponse to ‘Hormone therapy and loss of kidney function’
Ahmed, S. B., Zhang, J., & Hemmelgarn, B. R. (2009) · Kidney International · doi:10.1038/ki.2009.77
Neurosteroids in clinical practice: implications for women’s health
Genazzani, A. R., Bucci, F., Russo, N., Daino, D., Santoro, A. N., & Pluchino, N. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.120
Age Related Changes in Cognition and Brain: A Focus on Progestogens
Braden, B. B. (2012)
Progestérone et progestatifs de synthèse
Rozenbaum, H. (2009) · EMC - Gynécologie · doi:10.1016/s0246-1064(09)43131-1
Ahmed, M. (2017) · Digital Commons-TMC (Texas Medical Center)
Biodegradation of the steroid progesterone in surface waters
Ojoghoro, J. O. (2017) · Brunel University Research Archive (BURA) (Brunel University London)
Akbar, N., & Husnah, N. (2020) · Jurnal Penelitian Kesehatan "SUARA FORIKES" (Journal of Health Research "Forikes Voice") · doi:10.33846/sf11nk116
Dupree, L. (2019) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Indicaciones de la drospirenona más allá de la anticoncepción.
Hoz, F. J. E. D. L. (2021) · Revista Ciencias Biomédicas · doi:10.32997/rcb-2021-3372
Acebedo, S. L., & Ramirez, J. A. (2021) · Kirk-Othmer Encyclopedia of Chemical Technology · doi:10.1002/0471238961.1920051813151807.a01.pub2
Hermsmeyer, R. K., & Thompson, T. L. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4838-8_30
Stracquadanio, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-29223-2_4
Anastassakis, K. (2022) · Springer eBooks · doi:10.1007/978-3-031-08057-9_15
Bleeding Abnormalities During Menopause Hormone Therapy
Carpani, V. F., Giannini, A., Simoncini, T., & Genazzani, A. R. (2024) · ISGE series · doi:10.1007/978-3-031-55300-4_14
Dose-Dependent Effects of Oral Contraception on Emotion RecognitionPreprint
Lunge, J., & Welling, L. L. M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5154988
Zhang, Y., Qin, F., Guan, J., Ren, C., & Gao, G. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5825162
Estrogènes et pathologies neuropsychiatriques chez les femmes âgées
Ryan, J. L. (2010) · theses.fr (ABES) · doi:10.70675/b3559bf2z9a55z4f80zb317zb0d042d05a5c
The Effects of Oral Contraceptives on Muscle Hypertrophy
Phillips, M., Misra, M., & Raiser, S. N. (2026) · International Journal of Sports Medicine · doi:10.1055/a-2933-1360
“4 , 5 , 18 Additionally, existing studies that examine the effect of hormonal contracep - tives on muscle growth have produced inconsistent findings, and these contraceptives vary in contraceptive formulation.”
Patel, A. J., Karandikar, A. N., Miron-Ocampo, A., Karandikar, N. J., & Mangalam, A. K. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlag046
Al-Reshawee, F., & Alburkat, H. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16100514
“…profile of bioidentical progesterone differs meaningfully from that of synthetic progestogens, particularly with respect to breast tissue proliferation [24], and a system that delivers progesterone in appropriately timed pulses rather than continuously may further reduce exposure-related risks.”
Influential
Metadata
- Authors
- Stanczyk, F. Z.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Stanczyk, Frank Z
- ORCID
- Stanczyk, Frank Z
- Venue
- Steroids
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 68
- Issue
- 10-13
- Pages
- 879-890
- ISSN
- 0039-128X (ISSN-L)
- OpenAlex
- W2037043326
- Cited by
- 226
- References
- 37
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 5 · 2023: 5 · 2022: 13 · 2021: 7 · 2020: 11 · 2019: 15 · 2018: 15 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 11 · 2013: 15 · 2012: 8
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Steroids (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- progestins, progesterone derivatives, testosterone derivatives, pregnane derivatives, norethisterone, levonorgestrel, hepatic first-pass metabolism, prodrugs, structure-function relationship, androgenic activity, pharmacokinetics
- MeSH terms
- Animals, Female, Humans, Liver, Models, Chemical, Norethindrone, Pregnanes, Progestins, Structure-Activity Relationship, Time Factors, Levonorgestrel, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review